is a highly differentiated, multiproduct medical device
company employing a unique business model designed to
advance products from concept to commercialization much more
rapidly and with significantly less capital than the typical
medical device company
Jan 10, 2018 soaring more than 20 %.
These shares hit a52
week high of $13.07last year .
Recently these shareshave
risen three foldfrom $2.50 to over
$9.00. Pulling back and forming a solid base at $3.00 these
shares are poised to
challenge the $9.00 level once again . Biotech Reporter looks for a
from these levels setting ourinitial
target price at $9.00then advancing
once again testing the $13.07 level .
of Target Publishing Inc, and is a leading publisher of
todays market and investment news, commentary,
proprietary research and videos from seasoned
journalists, analysts and contributors covering the
financial markets and global economies. Leveraging our
extensive distribution network and social media
presence, we havecultivated
a valuable audieXnceof
engaged market enthusiasts, which in turn
delivers a variety of unique opportunities for industry
partnerships, corporate communications, market exposure
and investment. We
are paid cash compensation by the company only for the distribution of this report.